본문 바로가기
R&D JW, leading global new drug development
Home

Research Policy

Based on the long history and know-how in treatment and medicine field, the JW Holdings constantly researching and developing innovative new medicine.
We are targeting the diseases with high demand for medical unmet needs, concentrating on the development of innovative
new medicines using the JW’s unique technology, and conducting research activities in line with global trends through open innovation.
The JW Pharmaceutical has been focusing on the development of innovative new medicines with its key technologies as cancer stem cells,
regenerative medicine, and immune cancer medicines based on our long-established base technology.